» Articles » PMID: 21188629

The Association Between Two Polymorphisms in the TYMS Gene and Breast Cancer Risk: a Meta-analysis

Overview
Specialty Oncology
Date 2010 Dec 29
PMID 21188629
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Thymidylate synthase (TYMS), which catalyzes the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate, is a central enzyme in the folate metabolic pathway. Epidemiological studies have evaluated the association between TYMS gene polymorphisms and breast cancer susceptibility; however, the published data are still inconclusive. To derive a more precise assessment of this relationship, we performed a meta-analysis based on currently available data by searching PubMed, EMBASE databases, and the Cochrane Library. A total of 10 eligible studies were identified for the TYMS TSER polymorphism (six studies with 2,718 cases and 3,423 controls) and for the TYMS TS3'-UTR polymorphism (five studies with 1,969 cases and 2,290 controls). The overall odds ratio (OR) and the corresponding 95% confidence interval (CI) showed a statistical association between the TSER polymorphism and breast cancer risk under homozygote comparison (2R/2R vs. non-2R/non-2R; OR 1.25; 95% CI 1.04-1.50), allele contrast (2R vs. non-2R; OR 1.09; 95% CI 1.01-1.19) and the recessive model (OR 1.19; 95% CI 1.01-1.39). In the subgroup analysis by ethnicity, a statistically significant increase in cancer risk was found among Caucasians for homozygote comparison (OR 1.31; 95% CI 1.10-1.57), the allele contrast model (OR 1.12; 95% CI 1.02-1.23) and the dominant model (OR 1.40; 95% CI 1.00-1.95). For the TS3'-UTR polymorphism, significant effects were shown using the allele contrast model (OR 1.33; 95% CI 1.03-1.73). However, the TS3'-UTR polymorphism increased breast cancer risk among Asian women (del6 vs. ins6; OR 1.41; 95% CI 1.01-1.98) but not Caucasian women using the homozygote comparison. In conclusion, our meta-analysis suggests that the TSER polymorphism may increase susceptibility to breast cancer in the Caucasian population and the TS3'-UTR polymorphism may be a genetic determinant for developing breast cancer in the Asian population; therefore, ethnic background should be carefully considered in further studies.

Citing Articles

Biomarkers for Breast Adenocarcinoma Using In Silico Approaches.

Pandi J, Arulprakasam A, Dhandapani R, Ramanathan S, Thangavelu S, Chinnappan J Evid Based Complement Alternat Med. 2022; 2022:7825272.

PMID: 35280505 PMC: 8913068. DOI: 10.1155/2022/7825272.


Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma.

Li S, Zhao J, Lv L, Dong D Front Oncol. 2021; 11:762821.

PMID: 34858842 PMC: 8630669. DOI: 10.3389/fonc.2021.762821.


Variants of Genes Involved in Metabolism of Folate Among Patients with Breast Cancer: Association of 3R Allele with Susceptibility to Breast Cancer and Metastasis.

Rahimi Z, Bozorgi Zarini M, Rahimi Z, Shakiba E, Vaisi-Raygani A, Moradi M Iran J Pathol. 2021; 16(1):62-68.

PMID: 33391382 PMC: 7691710. DOI: 10.30699/ijp.2020.117676.2283.


3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.

Silva N, Santos A, Nogueira V, Carneiro C, Lima A BMC Cancer. 2020; 20(1):323.

PMID: 32295543 PMC: 7161242. DOI: 10.1186/s12885-020-06811-7.


Plasma Homocysteine and Polymorphisms of Genes Involved in Folate Metabolism Correlate with Gene Methylation Levels.

Coppede F, Stoccoro A, Tannorella P, Migliore L Metabolites. 2019; 9(12).

PMID: 31817852 PMC: 6950100. DOI: 10.3390/metabo9120298.